![Robert Felsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Felsch worked as the Controller & Vice President-Finance at Ardelyx, Inc. from 2020 to 2021.
He then served as the Senior Vice President & Controller at IGM Biosciences, Inc. from 2021 to 2022.
Following that, he held the position of Chief Accounting Officer & Senior VP-Finance at Ardelyx, Inc. from 2022 to 2024.
Mr. Felsch completed his undergraduate degree at the University of Southern California.
Anciens postes connus de Robert Felsch
| Sociétés | Poste | Fin |
|---|---|---|
| ARDELYX, INC. | Comptroller/Controller/Auditor | 15/11/2024 |
| IGM BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/01/2022 |
| ARDELYX, INC. | Comptroller/Controller/Auditor | 01/09/2021 |
Formation de Robert Felsch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
